Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

EMP2 is a novel therapeutic target for endometrial cancer stem cells.

Kiyohara MH, Dillard C, Tsui J, Kim SR, Lu J, Sachdev D, Goodglick L, Tong M, Torous VF, Aryasomayajula C, Wang W, Najafzadeh P, Gordon LK, Braun J, McDermott S, Wicha MS, Wadehra M.

Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12.

2.

Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease.

Li X, LeBlanc J, Elashoff D, McHardy I, Tong M, Roth B, Ippoliti A, Barron G, McGovern D, McDonald K, Newberry R, Graeber T, Horvath S, Goodglick L, Braun J.

Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):567-583. doi: 10.1016/j.jcmgh.2016.05.003. eCollection 2016 Sep.

3.

Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2.

Ho ME, Quek SI, True LD, Seiler R, Fleischmann A, Bagryanova L, Kim SR, Chia D, Goodglick L, Shimizu Y, Rosser CJ, Gao Y, Liu AY.

Oncotarget. 2016 Mar 29;7(13):15747-56. doi: 10.18632/oncotarget.7400.

4.

MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.

Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PAL, Gardner BK, Behbahan IS, Horvath S, Chia D, Mellinghoff IK, Hurvitz SA, Dubinett SM, Critchlow SE, Kurdistani SK, Goodglick L, Braas D, Graeber TG, Christofk HR.

Cell Rep. 2016 Feb 23;14(7):1590-1601. doi: 10.1016/j.celrep.2016.01.057. Epub 2016 Feb 11.

5.

High expression of AGR2 in lung cancer is predictive of poor survival.

Alavi M, Mah V, Maresh EL, Bagryanova L, Horvath S, Chia D, Goodglick L, Liu AY.

BMC Cancer. 2015 Oct 6;15:655. doi: 10.1186/s12885-015-1658-2.

6.

Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status.

Mah V, Alavi M, Márquez-Garbán DC, Maresh EL, Kim SR, Horvath S, Bagryanova L, Huerta-Yepez S, Chia D, Pietras R, Goodglick L.

PLoS One. 2015 May 22;10(5):e0127600. doi: 10.1371/journal.pone.0127600. eCollection 2015.

7.

Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.

Hamilton N, Márquez-Garbán D, Mah V, Fernando G, Elshimali Y, Garbán H, Elashoff D, Vadgama J, Goodglick L, Pietras R.

Biomed Res Int. 2015;2015:925703. doi: 10.1155/2015/925703. Epub 2015 Mar 22.

8.

SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.

Sun QY, Ding LW, Xiao JF, Chien W, Lim SL, Hattori N, Goodglick L, Chia D, Mah V, Alavi M, Kim SR, Doan NB, Said JW, Loh XY, Xu L, Liu LZ, Yang H, Hayano T, Shi S, Xie D, Lin DC, Koeffler HP.

J Pathol. 2015 Mar;235(4):559-70. doi: 10.1002/path.4482. Epub 2014 Dec 18.

9.

Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.

Qin Y, Fu M, Takahashi M, Iwanami A, Kuga D, Rao RG, Sudhakar D, Huang T, Kiyohara M, Torres K, Dillard C, Inagaki A, Kasahara N, Goodglick L, Braun J, Mischel PS, Gordon LK, Wadehra M.

J Biol Chem. 2014 May 16;289(20):13974-85. doi: 10.1074/jbc.M113.543728. Epub 2014 Mar 18.

10.

Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.

Fu M, Maresh EL, Helguera GF, Kiyohara M, Qin Y, Ashki N, Daniels-Wells TR, Aziz N, Gordon LK, Braun J, Elshimali Y, Soslow RA, Penichet ML, Goodglick L, Wadehra M.

Mol Cancer Ther. 2014 Apr;13(4):902-15. doi: 10.1158/1535-7163.MCT-13-0199. Epub 2014 Jan 21.

11.

The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Kazmi N, Márquez-Garbán DC, Aivazyan L, Hamilton N, Garon EB, Goodglick L, Pietras RJ.

Lung Cancer Manag. 2012 Dec;1(4):259-272.

12.

Prostate cancer cell phenotypes based on AGR2 and CD10 expression.

Ho ME, Quek SI, True LD, Morrissey C, Corey E, Vessella RL, Dumpit R, Nelson PS, Maresh EL, Mah V, Alavi M, Kim SR, Bagryanova L, Horvath S, Chia D, Goodglick L, Liu AY.

Mod Pathol. 2013 Jun;26(6):849-59. doi: 10.1038/modpathol.2012.238. Epub 2013 Jan 25.

13.

EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.

Gordon LK, Kiyohara M, Fu M, Braun J, Dhawan P, Chan A, Goodglick L, Wadehra M.

Oncogene. 2013 Nov 14;32(46):5369-76. doi: 10.1038/onc.2012.622. Epub 2013 Jan 21.

14.

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, Goparaju C.

N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050. Erratum in: N Engl J Med. 2012 Nov;367(18):1768.

15.

Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development.

Sullivan PS, Maresh EL, Seligson DB, Habeeb O, Wadehra M, Goodglick L, Dorigo O.

Mod Pathol. 2012 Aug;25(8):1140-8. doi: 10.1038/modpathol.2012.64. Epub 2012 Mar 30.

16.

Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer.

Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK.

Am J Physiol Lung Cell Mol Physiol. 2012 Jun 1;302(11):L1150-8. doi: 10.1152/ajplung.00384.2010. Epub 2012 Feb 17.

17.

A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface.

Li X, LeBlanc J, Truong A, Vuthoori R, Chen SS, Lustgarten JL, Roth B, Allard J, Ippoliti A, Presley LL, Borneman J, Bigbee WL, Gopalakrishnan V, Graeber TG, Elashoff D, Braun J, Goodglick L.

PLoS One. 2011;6(11):e26542. doi: 10.1371/journal.pone.0026542. Epub 2011 Nov 21.

18.

Lung cancer chemoprevention with celecoxib in former smokers.

Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D.

Cancer Prev Res (Phila). 2011 Jul;4(7):984-93. doi: 10.1158/1940-6207.CAPR-11-0078.

19.

Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface.

Presley LL, Ye J, Li X, Leblanc J, Zhang Z, Ruegger PM, Allard J, McGovern D, Ippoliti A, Roth B, Cui X, Jeske DR, Elashoff D, Goodglick L, Braun J, Borneman J.

Inflamm Bowel Dis. 2012 Mar;18(3):409-17. doi: 10.1002/ibd.21793. Epub 2011 Jun 22.

20.

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.

Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, Mah V, Rivera-Pazos CM, Chatterjee D, Vega MI, Maresh EL, Horvath S, Chia D, Bonavida B, Goodglick L.

BMC Cancer. 2011 Jun 21;11:259. doi: 10.1186/1471-2407-11-259.

21.

Protein expression based multimarker analysis of breast cancer samples.

Presson AP, Yoon NK, Bagryanova L, Mah V, Alavi M, Maresh EL, Rajasekaran AK, Goodglick L, Chia D, Horvath S.

BMC Cancer. 2011 Jun 8;11:230. doi: 10.1186/1471-2407-11-230.

22.

Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.

Fu M, Rao R, Sudhakar D, Hogue CP, Rutta Z, Morales S, Gordon LK, Braun J, Goodglick L, Wadehra M.

PLoS One. 2011;6(5):e19945. doi: 10.1371/journal.pone.0019945. Epub 2011 May 27.

23.

Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.

Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, Bagryanova L, Horvath S, Chia D, Garon E, Goodglick L, Pietras RJ.

Steroids. 2011 Aug;76(9):910-20. doi: 10.1016/j.steroids.2011.04.015. Epub 2011 May 8.

24.

Peripheral myelin protein-22 (PMP22) modulates alpha 6 integrin expression in the human endometrium.

Rao RG, Sudhakar D, Hogue CP, Amici S, Gordon LK, Braun J, Notterpek L, Goodglick L, Wadehra M.

Reprod Biol Endocrinol. 2011 Apr 25;9:56. doi: 10.1186/1477-7827-9-56.

25.

Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

Mah V, Marquez D, Alavi M, Maresh EL, Zhang L, Yoon N, Horvath S, Bagryanova L, Fishbein MC, Chia D, Pietras R, Goodglick L.

Lung Cancer. 2011 Nov;74(2):318-25. doi: 10.1016/j.lungcan.2011.03.009. Epub 2011 Apr 20.

26.

Pentraxin-3 is a novel biomarker of lung carcinoma.

Diamandis EP, Goodglick L, Planque C, Thornquist MD.

Clin Cancer Res. 2011 Apr 15;17(8):2395-9. doi: 10.1158/1078-0432.CCR-10-3024. Epub 2011 Jan 21.

27.

Differential expression of anterior gradient gene AGR2 in prostate cancer.

Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L.

BMC Cancer. 2010 Dec 13;10:680. doi: 10.1186/1471-2407-10-680.

28.

Higher levels of GATA3 predict better survival in women with breast cancer.

Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, Mah V, Bose S, Chia D, Chang HR, Goodglick L.

Hum Pathol. 2010 Dec;41(12):1794-801. doi: 10.1016/j.humpath.2010.06.010.

29.

Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer.

Ooi AT, Mah V, Nickerson DW, Gilbert JL, Ha VL, Hegab AE, Horvath S, Alavi M, Maresh EL, Chia D, Gower AC, Lenburg ME, Spira A, Solis LM, Wistuba II, Walser TC, Wallace WD, Dubinett SM, Goodglick L, Gomperts BN.

Cancer Res. 2010 Aug 15;70(16):6639-48. doi: 10.1158/0008-5472.CAN-10-0455.

30.

Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.

Fu M, Maresh EL, Soslow RA, Alavi M, Mah V, Zhou Q, Iasonos A, Goodglick L, Gordon LK, Braun J, Wadehra M.

Clin Cancer Res. 2010 Aug 1;16(15):3954-63. doi: 10.1158/1078-0432.CCR-10-0368.

31.

Elevated MED28 expression predicts poor outcome in women with breast cancer.

Yoon NK, Maresh EL, Elshimali Y, Li A, Horvath S, Seligson DB, Chia D, Goodglick L.

BMC Cancer. 2010 Jun 28;10:335. doi: 10.1186/1471-2407-10-335.

32.

Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.

Habeeb O, Goodglick L, Soslow RA, Rao RG, Gordon LK, Schirripa O, Horvath S, Braun J, Seligson DB, Wadehra M.

Cancer. 2010 Oct 15;116(20):4718-26. doi: 10.1002/cncr.25259.

33.

Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma.

Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, Sharma S, Dubinett SM.

Clin Cancer Res. 2009 Nov 15;15(22):6820-9. doi: 10.1158/1078-0432.CCR-09-1558. Epub 2009 Nov 3.

34.

Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.

Planque C, Kulasingam V, Smith CR, Reckamp K, Goodglick L, Diamandis EP.

Mol Cell Proteomics. 2009 Dec;8(12):2746-58. doi: 10.1074/mcp.M900134-MCP200. Epub 2009 Sep 23.

35.

Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.

Yoon NK, Seligson DB, Chia D, Elshimali Y, Sulur G, Li A, Horvath S, Maresh E, Mah V, Bose S, Bonavida B, Goodglick L.

Cancer Biomark. 2009;5(4):215-24. doi: 10.3233/CBM-2009-0106.

36.

Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).

Morales SA, Mareninov S, Coulam P, Wadehra M, Goodglick L, Braun J, Gordon LK.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4949-56. doi: 10.1167/iovs.08-3315. Epub 2009 Jun 3.

37.

Global levels of histone modifications predict prognosis in different cancers.

Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S, Wang Q, Chia D, Goodglick L, Kurdistani SK.

Am J Pathol. 2009 May;174(5):1619-28. doi: 10.2353/ajpath.2009.080874. Epub 2009 Apr 6.

38.

Targeting aromatase and estrogen signaling in human non-small cell lung cancer.

Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ.

Ann N Y Acad Sci. 2009 Feb;1155:194-205. doi: 10.1111/j.1749-6632.2009.04116.x.

39.

T-cell responses to survivin in cancer patients undergoing radiation therapy.

Schaue D, Comin-Anduix B, Ribas A, Zhang L, Goodglick L, Sayre JW, Debucquoy A, Haustermans K, McBride WH.

Clin Cancer Res. 2008 Aug 1;14(15):4883-90. doi: 10.1158/1078-0432.CCR-07-4462.

40.

FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction.

Morales SA, Mareninov S, Wadehra M, Zhang L, Goodglick L, Braun J, Gordon LK.

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):462-9. doi: 10.1167/iovs.07-1598. Epub 2008 May 9.

41.

A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.

Planque C, Li L, Zheng Y, Soosaipillai A, Reckamp K, Chia D, Diamandis EP, Goodglick L.

Clin Cancer Res. 2008 Mar 1;14(5):1355-62. doi: 10.1158/1078-0432.CCR-07-4117.

42.

RIN1 is a breast tumor suppressor gene.

Milstein M, Mooser CK, Hu H, Fejzo M, Slamon D, Goodglick L, Dry S, Colicelli J.

Cancer Res. 2007 Dec 15;67(24):11510-6.

43.

Aromatase expression predicts survival in women with early-stage non small cell lung cancer.

Mah V, Seligson DB, Li A, Márquez DC, Wistuba II, Elshimali Y, Fishbein MC, Chia D, Pietras RJ, Goodglick L.

Cancer Res. 2007 Nov 1;67(21):10484-90.

44.

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.

Seligson DB, Hongo F, Huerta-Yepez S, Mizutani Y, Miki T, Yu H, Horvath S, Chia D, Goodglick L, Bonavida B.

Clin Cancer Res. 2007 Oct 15;13(20):6056-63.

45.

Epithelial membrane protein 2 modulates infectivity of Chlamydia muridarum (MoPn).

Shimazaki K, Wadehra M, Forbes A, Chan AM, Goodglick L, Kelly KA, Braun J, Gordon LK.

Microbes Infect. 2007 Jul;9(8):1003-10. Epub 2007 Apr 18.

PMID:
17544801
46.

Direct electronic detection of prostate-specific antigen in serum.

Briman M, Artukovic E, Zhang L, Chia D, Goodglick L, Gruner G.

Small. 2007 May;3(5):758-62. No abstract available.

PMID:
17352433
47.

Estrogen receptor signaling pathways in human non-small cell lung cancer.

Márquez-Garbán DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ.

Steroids. 2007 Feb;72(2):135-43. Epub 2007 Feb 5.

48.

Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.

Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L.

Hum Pathol. 2006 Dec;37(12):1583-91. Epub 2006 Aug 10.

PMID:
16949910
49.

Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.

Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, Lin Y, Goodglick L, Krysan K, Fishbein MC, Hong L, Lai C, Cameron RB, Gemmill RM, Drabkin HA, Dubinett SM.

Cancer Res. 2006 May 15;66(10):5338-45.

50.

Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.

Hoang B, Zhu L, Shi Y, Frost P, Yan H, Sharma S, Sharma S, Goodglick L, Dubinett S, Lichtenstein A.

Blood. 2006 Jun 1;107(11):4484-90. Epub 2006 Feb 23.

Supplemental Content

Loading ...
Support Center